https://government.economictimes.indiatimes.com/tag/tocilizumab
Tocilizumab - Latest tocilizumab , Information & Updates - Government -ET Government
ETGovernment.com brings latest tocilizumab news, views and updates from all top sources for the Indian Government industry.
latest informationtocilizumabupdatesgovernmentet
https://pmc.ncbi.nlm.nih.gov/articles/PMC7953459/
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia - PMC
Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of...
tocilizumabhospitalizedpatientsseverecovid
https://adisinsight.springer.com/drugsafety/803212906?error=cookies_not_supported&code=879651c2-9ed9-4a3c-93e0-63a3b1b1cd4f
Methylprednisolone/tocilizumab - AdisInsight
A 69-year-old woman developed pyogenic spondylodiscitis, following treatment with tocilizumab and methylprednisolone [not all routes and dosages stated].The
methylprednisolonetocilizumabadisinsight
https://adisinsight.springer.com/drugsafety/803856737?error=cookies_not_supported&code=8f40b4cb-5c63-4d35-aabd-ec3b88e3b58b
Anti-CD19-CAR-transduced-T-cells/Tocilizumab - AdisInsight
In a study conducted between November 2019 to April 2021, involving 20 patients, four patients [ages and sexes not stated] were described who developed immune
t cellsanticartocilizumabadisinsight
https://pure.psu.edu/en/publications/tocilizumab-for-the-treatment-of-chronic-antibody-mediated-reject/
Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant...
for the
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab
Definition of tocilizumab - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition oftocilizumabncidrugdictionary
https://about.ebsco.com/clinical-decisions/dynamed-solutions/about/ebm-focus/tocilizumab-increases-remission-and-reduces
Tocilizumab increases remission and reduces corticosteroid use in giant cell arteritis | EBM Focus
https://talkingrheumatologyresearch.buzzsprout.com/1972486/episodes/15623502-ep-47-relapse-after-cessation-of-weekly-tocilizumab-for-giant-cell-arteritis?t=0
Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis
Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. Looking at relapse rates and key risk...
https://adisinsight.springer.com/drugsafety/803489085?error=cookies_not_supported&code=fa6143f5-3a4b-485e-a84b-bc3b24bdd5ed
Tocilizumab - AdisInsight
In a report, a 40-year-old man developed viral myocarditis and worsening of COVID-19 during off-label use of tocilizumab for COVID-19 and a 69-year-old woman
tocilizumabadisinsight
https://pubmed.ncbi.nlm.nih.gov/30945743/
Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk...
Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum
https://adisinsight.springer.com/drugsafety/803151588?error=cookies_not_supported&code=8f324796-74a3-4b73-9218-bb9e73600766
Tocilizumab - AdisInsight
In a study, 8 patient's [4 girls and 4 boys; aged 3-21 years] developed various toxicities [chickenpox, ecchymosis, eczema, elevated ALT, AST and ALP, skin
tocilizumabadisinsight
https://publikationen.uni-tuebingen.de/xmlui/handle/10900/139073?show=full
Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind,...
familial mediterranean feverfor the
https://adisinsight.springer.com/drugsafety/803929834?error=cookies_not_supported&code=739b3e30-4d16-4f45-a971-c60de2bc66ec
Tocilizumab - AdisInsight
A patient [age and sex not stated] with systemic sclerosis received tocilizumab [route, dose and treatment duration not stated]. The patient was reported to
tocilizumabadisinsight
https://adisinsight.springer.com/drugsafety/803827280?error=cookies_not_supported&code=9cfe0b4e-c5b9-4b8c-be13-e468af545160
Tocilizumab - AdisInsight
In a retrospective single-center study conducted between April 2000 and December 2021, one patient [age and sex not stated] was described, who developed
tocilizumabadisinsight
https://adisinsight.springer.com/drugsafety/803771506?error=cookies_not_supported&code=4e99b6ba-35f9-4826-8184-5c23dfec77e1
Dexamethasone/tocilizumab - AdisInsight
A 64-year-old man developed chronic cavitary pulmonary aspergillosis (CCPA) during treatment with off-label tocilizumab and off-label dexamethasone for severe
dexamethasonetocilizumabadisinsight
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.790547/full
Frontiers | Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney...
Introduction: Chronic antibody-mediated rejection (cAMR) has very few effective therapeutic options. Interleukin-6 is an attractive target because it is invo...
in the
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0251378
The impact of tocilizumab on respiratory support states transition and clinical outcomes in...
Background The benefit of tocilizumab on mortality and time to recovery in people with severe COVID pneumonia may depend on appropriate timing. The objective...
https://health.economictimes.indiatimes.com/news/industry/govt-makes-interim-allocation-of-covid-19-treatment-drug-tocilizumab-to-states/82302046
COVID-19 Patients: Govt makes interim allocation of Covid-19 treatment drug tocilizumab to states,...
COVID-19 Patients: In a letter, Pharma Joint Secretary Navdeep Rinwa and Health and Family Welfare Ministry Director Rajiv Wadhawan said the drug went out of...
https://adisinsight.springer.com/drugsafety/803924231?error=cookies_not_supported&code=e70101a7-629e-4c2d-a4ca-3ffb17fe7b07
Tocilizumab - AdisInsight
A 56-year-old man with human herpesvirus 8 (HHV-8)-associated multicentric Castleman disease (MCD) developed progressive polyneuropathy and worsening systemic
tocilizumabadisinsight
https://pubmed.ncbi.nlm.nih.gov/30865069/
Subcutaneous Tocilizumab for Thyroid Eye Disease: Simplified Dosing and Delivery
Intravenous tocilizumab has been demonstrated to be an effective disease modifying agent in the treatment of moderate to severe active thyroid eye disease. The...
thyroid eye diseasesubcutaneoustocilizumabsimplifieddosing
https://buy-roactemra-tocilizumab-online.blogspot.com/
Buy RoActemra (tocilizumab) online
buytocilizumabonline
https://digitalcommons.wustl.edu/oa_4/5612/
"Tocilizumab prophylaxis following axicabtagene ciloleucel in relapsed " by Frederick L Locke,...
Axicabtagene ciloleucel (axi-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved in patients with relapsed/refractory (R/R)...
axicabtagene ciloleuceltocilizumabprophylaxisfollowing
https://publikationen.uni-tuebingen.de/xmlui/handle/10900/53057
Interstitial Granulomatous Dermatitis With Arthritis Responding to Tocilizumab
interstitialdermatitisarthritisrespondingtocilizumab
https://pubmed.ncbi.nlm.nih.gov/34588793/
Implications for Systemic Approaches to COVID-19: Effect Sizes of Remdesivir, Tocilizumab,...
Nonstandard adjunctive care appeared to have comparable or superior effects in comparison to Remdesivir and Tocilizumab on the inflammatory markers most...
https://adisinsight.springer.com/drugsafety/803514082?error=cookies_not_supported&code=387dc250-e91f-448e-8812-366678cc9058
Acenocoumarol/tocilizumab interaction - AdisInsight
A 49-year-old woman developed cutaneous symptoms resembling purpura fulminans, fibrinoid necrosis and thrombosis following concomitant administration of
acenocoumaroltocilizumabinteractionadisinsight
https://www.imperial.ac.uk/news/218553/global-trial-reports-tocilizumab-covid-19-pneumonia/
Global trial reports on use of tocilizumab in COVID-19 pneumonia | Imperial News | Imperial College...
The anti-inflammatory treatment tocilizumab does not significantly improve outcomes for patients with severe COVID-19 pneumonia, a trial has found.
https://blogs.nejm.org/hiv-id-observations/index.php/tag/tocilizumab/
tocilizumab Archives - HIV and ID Observations HIV and ID Observations
tocilizumabarchivesidobservations
https://portal.fis.tum.de/en/publications/tocilizumab-in-covid-19-therapy-who-benefits-and-how/
Tocilizumab in COVID-19 therapy: who benefits, and how? - Technical University of Munich
https://adisinsight.springer.com/drugsafety/803604838?error=cookies_not_supported&code=ecbcd414-d89c-489c-9c3e-0520a7f085cc
Rituximab/tocilizumab - AdisInsight
A 52-year-old woman received off-label treatment with tocilizumab for neuromyelitis optica (NMO). Additionally, she exhibited lack of efficacy while receiving
rituximabtocilizumabadisinsight
https://www.mdpi.com/2079-6382/11/8/1078
Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A...
(1) Background: The efficacy of tocilizumab in COVID-19 has been doubted. The study aimed to investigate factors affecting disease stability and response to...
https://www.actemrahcp.com/ra.html
ACTEMRA® (tocilizumab) Rheumatoid Arthritis (RA) Treatment Information for Rheumatologists
Find additional ACTEMRA® (tocilizumab) information, including a dosing calculator, RA payer coverage, and medication guide. See Full Safety and Boxed Warnings...
rheumatoid arthritistreatment informationtocilizumabrarheumatologists
https://adisinsight.springer.com/drugs/800050067?error=cookies_not_supported&code=9db6bd97-54bc-44ef-81f6-210fccdaff53
Tocilizumab biosimilar - Gedeon Richter/Mochida Pharmaceutical - AdisInsight
A biosimilar of tocilizumab [see ADISInsight drug profile800010359] is being developed by Gedeon Richter and Mochida Pharmaceuticals, for the treatment of
gedeon richtertocilizumabbiosimilarmochidapharmaceutical
https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/Racial-and-Ethnic-Disparities-in-Severe/991022170440804721
Racial and Ethnic Disparities in Severe Ischemic Manifestations and Tocilizumab Use Among Patients...
Mar 24, 2026 - Giant cell arteritis (GCA) has traditionally been recognized as more common in White populations, but there is limited understanding of its epidemiology and...
racial and ethnic disparities
https://amicor.blogspot.com/2015/04/tocilizumab-actemra.html
AMICOR: Tocilizumab (Actemra)
amicortocilizumabactemra
https://boris-portal.unibe.ch/entities/publication/5433147b-90b7-46b1-b3c1-7681f4debc0f
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment...
https://www.mdpi.com/2077-0383/12/2/424
Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to...
Background: Desensitization strategies improve access to transplantation in highly sensitized kidney transplant candidates. Tocilizumab could be a valuable...
https://adisinsight.springer.com/drugsafety/803925796?error=cookies_not_supported&code=af4593bc-678a-49ee-abd5-83afdad3e390
Adalimumab/Tocilizumab - AdisInsight
A six-year-old boy developed polyarticular juvenile idiopathic arthritis (JIA) following allogeneic haematopoietic stem cell transplantation (allo-HSCT) for
adalimumabtocilizumabadisinsight
https://pubmed.ncbi.nlm.nih.gov/36083403/
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world...
In-hospital mortality, progression to MV and LOS were not significantly different in patients treated with tocilizumab or baricitinib additionally to standard...
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.732792/full
Frontiers | Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by...
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was isolated in January 2020 and, on March, the WHO declared the status of a pandemic. It ca...
https://tobias-lib.ub.uni-tuebingen.de/xmlui/handle/10900/139073
Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind,...
familial mediterranean feverfor the
https://www.semanticscholar.org/topic/tocilizumab-Prefilled-Syringe-%5BActemra%5D/11793023
tocilizumab Prefilled Syringe [Actemra] | Semantic Scholar
prefilled syringetocilizumabactemrasemanticscholar
https://adisinsight.springer.com/drugsafety/803849351?error=cookies_not_supported&code=2af856c4-c18d-4419-91e2-244e143fe7e3
Tocilizumab - AdisInsight
A 48-year-old woman developed allergic reaction during treatment with tocilizumab for systemic scleroderma [dosage, route, duration of treatment to reaction
tocilizumabadisinsight
https://pandemics.utoronto.ca/resources/strategies-to-manage-tocilizumab-supply-during-the-covid-19-pandemic/
Strategies to Manage Tocilizumab Supply During the COVID-19 Pandemic | Institute of Health...
Nov 26, 2024 - Tocilizumab is an anti-inflammatory medication that acts by inhibiting interleukin-6 (IL-6) and is shown to improve outcomes including mortality in patients...
https://adisinsight.springer.com/drugsafety/803924652?error=cookies_not_supported&code=34260eef-f7cd-4fe2-a108-36600e109cd9
Teprotumumab/Tocilizumab - AdisInsight
Twenty-two patients with thyroid eye disease received teprotumumab and 22 received tocilizumab, with adverse events reported in both groups during treatment.
tocilizumabadisinsight